Pulmonx Corporation provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Its products include Zephyr Endobronchial Valve and Chartis Pulmonary Assessment System. The company also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service. It serves emphysema patients globally and is headquartered in Redwood City, California.